Zacks Investment Research on MSN9d
Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug
Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...
Contract Pharma2d
Fill-Finish Contract Manufacturing for Biologics and Vaccines
BioPlan Associates presents research and projections on the pharma sterile fill-finish industry’s future over the next 10 ...
Business Insider29d
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals ...
Morningstar1mon
Regeneron Gets New FDA Review of Linvoseltamab for Multiple Myeloma
Regeneron on Tuesday said the FDA's acceptance follows the resolution of its third-party fill/finish manufacturing issue, which was the sole issue the agency identified when it turned away the ...
MarketWatch29d
Regeneron Gets New FDA Review of Linvoseltamab for Multiple Myeloma
Regeneron Pharmaceuticals said the Food and Drug Administration has accepted its resubmitted application seeking approval of linvoseltamab for certain patients with the blood cancer multiple myeloma.
Yahoo Finance29d
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals ... resubmission follows the resolution of third-party fill/finish manufacturing issues, which was the sole ...